Next Generation News and Research

RSS

Chakra Biotech completes MYR18.2m Series B investment round

Chakra Biotech Sdn Bhd, a Malaysian based Contract Research Organization, has completed a MYR18.2m Series B funding round. This brings total funding for the company to MYR20.0m. Malaysian Life Sciences Capital Fund Ltd. (MLSCF) and the Malaysian Technology Development Corporation Sdn Bhd (MTDC) participated in the round.

29 Mar 2010

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.

29 Mar 2010

Genome sequencing of tumors biopsied from women with invasive breast cancer

Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women.

27 Mar 2010

AngioScore receives FDA marketing clearance for PTA Scoring Balloon Catheter

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AngioSculpt® PTA Scoring Balloon Catheter for dilatation of lesions in renal arteries.

26 Mar 2010

Dell unveils Medical Archiving and PowerEdge C 6100 solutions to boost healthcare efficiency

Dell today unveiled solutions to enable healthcare, higher-education and government organizations to better use technology to manage data, conduct research and fulfill their missions in a more efficient and secure manner.

26 Mar 2010

Fairbanks Institute for Healthy Communities introduces INbank biorepository

The Fairbanks Institute for Healthy Communities, the Indianapolis not-for-profit organization working to improve community health, announced today the creation of INbank™, a next generation biorepository that will provide scientists with an important resource for research on chronic diseases of aging.

26 Mar 2010

US patent reinforces Ikonisys' position in digital image-analysis industry

Ikonisys, Inc., a leading provider of next-generation, cell-based diagnostic solutions, announced today that the United States Patent and Trademark Office has issued the company United States Patent No. 7,660,454 entitled “Process for identifying FISH signals.”

25 Mar 2010

Parata Systems, Pharmacy Times launch The Next-Generation Pharmacist Program

Parata Systems and Pharmacy Times have joined forces to salute pharmacy professionals who are defining the future of pharmacy by launching The Next-Generation Pharmacist Program.

24 Mar 2010

Ambry Genetics introduces a suite of genetic tests to pinpoint the cause of mental retardation

Ambry Genetics today introduced The Ambry X-Linked Mental Retardation SuperPANEL™, a suite of genetic tests expected to pinpoint the cause of intellectual disability and X-linked mental retardation (XLMR).

24 Mar 2010

DSM Biomedical expands resources and operations in the U.S. and Europe

DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company’s portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.

23 Mar 2010

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

Scientists at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center were awarded a five-year $7.5 million grant to tease apart - in the most comprehensive way ever devised -the role of a single protein receptor in breast cells in cancer development and treatment.

22 Mar 2010

SeeChange Health launches first health insurance company in California

SeeChange Health today launched the first new value-based health insurance company in California, offering personalized, value-based health plans that provide incentives to encourage individuals to play an active role in their health management and improve their quality of life. As the first value-based health insurance company to launch in the United States, SeeChange Health brings affordable, next-generation insurance designs to the employer group market.

22 Mar 2010

PharmAthene to provide update on contract modification suspension

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that in addition to its year end results, it will provide an update on the contract modification suspension it received on Friday, March 19, 2010.

22 Mar 2010

CRi to distribute 3DHISTECH’s digital slide scanners and software applications in North America

Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH’s full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi’s offerings in the rapidly growing digital pathology market.

22 Mar 2010

FDA's new rule prohibits sale of cigarettes to children

The U.S. Food and Drug Administration issued a final rule containing a broad set of federal requirements designed to significantly curb access to and the appeal of cigarettes and smokeless tobacco products to children and adolescents in the United States. Published March 19, 2010, the new rule becomes effective June 22, 2010, and has the force and effect of law.

22 Mar 2010

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children’s Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.

18 Mar 2010

Humedica, Anceta unveil health care data solutions at AMGA 2010 Annual Conference

Humedica, a next-generation clinical informatics company, and Anceta, the healthcare informatics subsidiary of the American Medical Group Association, today announced the launch of Humedica MinedShare™ Ambulatory as well as AMGA’s Anceta Collaborative Data Warehouse at the AMGA 2010 Annual Conference, taking place now through March 20 in New Orleans.

18 Mar 2010

Vycor Medical's VBAS medical retraction device advances neurosurgical technology

Vycor Medical, Inc., a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.

18 Mar 2010

SC Johnson announces collaboration with BMGF on global efforts to combat malaria

SC Johnson, A Family Company, today announced a collaboration with the Bill & Melinda Gates Foundation on global efforts to combat malaria. The organizations will jointly support research programs conducted by Cornell University Center for Sustainable Global Enterprise and a consortium of Indonesian research institutions to advance the development and use of consumer products in the fight against the spread of the disease.

18 Mar 2010

RainDance Technologies partners with Ambry Genetics to provide sequence enrichment solution for clinical and research studies

Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.

18 Mar 2010

Next Generation News and Research

Chakra Biotech completes MYR18.2m Series B investment round

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

Genome sequencing of tumors biopsied from women with invasive breast cancer

AngioScore receives FDA marketing clearance for PTA Scoring Balloon Catheter

Dell unveils Medical Archiving and PowerEdge C 6100 solutions to boost healthcare efficiency

Fairbanks Institute for Healthy Communities introduces INbank biorepository

US patent reinforces Ikonisys' position in digital image-analysis industry

Parata Systems, Pharmacy Times launch The Next-Generation Pharmacist Program

Ambry Genetics introduces a suite of genetic tests to pinpoint the cause of mental retardation

DSM Biomedical expands resources and operations in the U.S. and Europe

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

SeeChange Health launches first health insurance company in California

PharmAthene to provide update on contract modification suspension

CRi to distribute 3DHISTECH’s digital slide scanners and software applications in North America

FDA's new rule prohibits sale of cigarettes to children

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Humedica, Anceta unveil health care data solutions at AMGA 2010 Annual Conference

Vycor Medical's VBAS medical retraction device advances neurosurgical technology

SC Johnson announces collaboration with BMGF on global efforts to combat malaria

RainDance Technologies partners with Ambry Genetics to provide sequence enrichment solution for clinical and research studies

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News